4-aminobenzoic acid and trametinib

4-aminobenzoic acid has been researched along with trametinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bendszus, M; Berberich, A; Breckwoldt, MO; Ciprut, S; Fischer, M; Hielscher, T; Hucke, N; Kessler, T; Lemke, D; Oezen, I; Platten, M; Pusch, S; Ruebmann, P; Sahm, F; Schmitt, LM; Thomé, CM; von Deimling, A; Wick, W	1

Other Studies

1 other study(ies) available for 4-aminobenzoic acid and trametinib

Article	Year
Targeting Resistance against the MDM2 Inhibitor RG7388 in Glioblastoma Cells by the MEK Inhibitor Trametinib. Clinical cancer research : an official journal of the American Association for Cancer Research, 2019, 01-01, Volume: 25, Issue:1 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Drug Resistance, Neoplasm; Glioblastoma; Heterografts; Humans; Insulin-Like Growth Factor Binding Protein 1; Mice; para-Aminobenzoates; Proto-Oncogene Proteins c-mdm2; Pyridones; Pyrimidinones; Pyrrolidines; Signal Transduction; Tumor Suppressor Protein p53	2019

Article

Year

Targeting Resistance against the MDM2 Inhibitor RG7388 in Glioblastoma Cells by the MEK Inhibitor Trametinib.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2019, 01-01, Volume: 25, Issue:1

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Drug Resistance, Neoplasm; Glioblastoma; Heterografts; Humans; Insulin-Like Growth Factor Binding Protein 1; Mice; para-Aminobenzoates; Proto-Oncogene Proteins c-mdm2; Pyridones; Pyrimidinones; Pyrrolidines; Signal Transduction; Tumor Suppressor Protein p53

2019